DR. M. STUBBE
0842.501.022 · rovalta.com · 23/09/2026
DR. M. STUBBE
Overview
What does DR. M. STUBBE do?
DR. M. STUBBE is a Private limited company incorporated in 2012. Its main activity is: Other human health activities. Its registered office is in Sint-Pieters-Leeuw.
1600 Sint-Pieters-Leeuw · FlandreSee on map
Trend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||
| Gross margin | 187,5 k € | -8.6% | 205 k € | +32.4% | 154,8 k € | +23.2% | 125,7 k € | -12.4% | 143,4 k € | +27.3% | 112,7 k € | -10.4% | 125,7 k € | +18.1% | 106,5 k € | -40.8% | 179,7 k € | +21.2% | 148,2 k € | +72.1% | 86,1 k € |
| EBITDA | 186,4 k € | -6.9% | 200,3 k € | +30.7% | 153,2 k € | +23.8% | 123,7 k € | -12.7% | 141,8 k € | +27.7% | 111 k € | -10.8% | 124,5 k € | +19.0% | 104,6 k € | -41.4% | 178,5 k € | +21.4% | 147 k € | +72.9% | 85 k € |
| Operating result | 158,4 k € | -10.0% | 176 k € | +31.0% | 134,3 k € | +24.3% | 108,1 k € | -14.0% | 125,7 k € | +28.7% | 97,6 k € | -12.4% | 111,5 k € | +20.0% | 92,9 k € | -44.7% | 168,1 k € | +18.6% | 141,8 k € | +78.6% | 79,4 k € |
| Net result | 114,3 k € | -8.4% | 124,8 k € | +32.7% | 94,1 k € | +24.5% | 75,5 k € | -16.1% | 90 k € | +29.9% | 69,3 k € | +0.7% | 68,8 k € | +14.6% | 60 k € | -38.7% | 98 k € | +2.7% | 95,4 k € | +75.5% | 54,4 k € |
| Balance sheet | |||||||||||||||||||||
| Equity | 591,4 k € | +5.2% | 562,3 k € | +11.0% | 506,8 k € | -27.0% | 694,3 k € | +3.8% | 668,7 k € | +47.5% | 453,3 k € | +18.0% | 384 k € | +21.8% | 315,2 k € | +23.5% | 255,1 k € | +57.3% | 162,2 k € | +143% | 66,8 k € |
| Total assets | 625,9 k € | +4.2% | 600,8 k € | +13.5% | 529,4 k € | -26.3% | 718,2 k € | -1.2% | 727,2 k € | +48.0% | 491,5 k € | +13.7% | 432,3 k € | +17.9% | 366,7 k € | +19.6% | 306,6 k € | +44.1% | 212,7 k € | +87.4% | 113,5 k € |
| Cash | 475,2 k € | +18.8% | 400 k € | -18.4% | 490,1 k € | -26.6% | 668,1 k € | -0.8% | 673,3 k € | +51.3% | 445,1 k € | +63.9% | 271,5 k € | +17.7% | 230,7 k € | -10.1% | 256,7 k € | +45.3% | 176,6 k € | +96.3% | 90 k € |
| Debts | 34,5 k € | -10.4% | 38,5 k € | +70.1% | 22,6 k € | -5.3% | 23,9 k € | -59.2% | 58,5 k € | +53.0% | 38,2 k € | -20.9% | 48,3 k € | -6.1% | 51,5 k € | +0.1% | 51,4 k € | +1.9% | 50,5 k € | +8.1% | 46,7 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 7 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/08/2026 | 30/06/2025 | 25/07/2024 | 31/08/2023 | 07/07/2022 | 06/07/2021 |
| General meeting | 31/07/2026 | 25/06/2025 | 21/06/2024 | 16/08/2023 | 14/06/2022 | 31/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
14 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 31/07/2026 | 24/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 25/06/2025 | 30/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 21/06/2024 | 25/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 16/08/2023 | 31/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 14/06/2022 | 07/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 31/05/2021 | 06/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 02/06/2020 | 17/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 28/06/2019 | 27/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 29/06/2018 | 26/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/06/2017 | 31/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 16/09/2016 | 05/10/2016 | Dutch | |
| Abridged model | 31/12/2014 | 11/08/2015 | 20/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 31/07/2014 | 22/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/08/2013 | 30/08/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 7 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025114,3 k €↓
- 2024Annual accounts 2024124,8 k €↑
- 2023Annual accounts 202394,1 k €↑
- 2023Name changeDR. M. Stubbe
- 2022Annual accounts 202275,5 k €↓
- 2021Annual accounts 202190 k €↑
- 2018Annual accounts 201869,3 k €↑
- 2017Annual accounts 201768,8 k €↑
- 2016Annual accounts 201660 k €↓
- 2015Annual accounts 201598 k €↑
- 2013Annual accounts 201395,4 k €↑
- 2012Annual accounts 201254,4 k €
- 09/01/2012IncorporationPrivate limited company
- 2012Name changeDr. M. Stubbe - Reumatologie